Compass Therapeutics
CMPX · NASDAQ
$0.8333−$0.0017 (−0.20%)TodayMarket closed ·
Prev close $0.835
About CMPX
- Employees
- 39
- Headquarters
- Boston, Massachusetts
- Listed
- Nov 13, 2020
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- compasstherapeutics.com
Leadership
| Name | Title | Since |
|---|---|---|
| Carl Gordon | — | — |
| Thomas Schuetz | — | 2014 |
| Barry Shin | — | — |
| Neil Lerner | — | — |
| Jonathan Anderman | — | — |
| James Boylan | — | — |
| Ellen Chiniara | — | — |
| Philip Ferneau | — | — |
| Mary Gray | — | — |
| Richard Lindahl | — | — |
Suppliers and customers
Price correlation is over one year: 1 means the stocks move together, -1 opposite
| Company | Relationship | Correlation |
|---|---|---|
| ABL Bio | Supplier and customer | -0.60 |
| Handok | Supplier and customer | — |
Similar companies
Companies in the same industry as Compass Therapeutics
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.